¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Contact Lens Cleaning Solution Misc"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • immediate contact
    Áï½ÃÁ¢ÃË
  • indirect contact
    °£Á¢Á¢ÃË
  • intercellular contact
    ¼¼Æ÷»çÀÌÁ¢ÃË, ¼¼Æ÷°£Á¢ÃË
  • intercellular contact layer
    ¼¼Æ÷»çÀÌÁ¢ÃËÃþ, ¼¼Æ÷°£Á¢ÃËÁõ
  • photoallergic contact dermatitis
    ±¤¾Ë·¹¸£±âÁ¢ÃËÇǺο°
  • primary contact
    ÀÏÂ÷Á¢ÃË
  • proximal contact
    ÀÎÁ¢¸éÁ¢ÃË
  • anisotonic solution
    ºñµîÀå¾×
  • aqueous solution
    ¼ö¿ë¾×, ¹°¿ë¾×
  • aseptic solution
    ¹«±Õ¾×
  • alkaline solution
    ¾ËÄ®¸®¿ë¾×
  • bleaching solution
    Ç¥¹é¿ë¾×
  • balanced salt solution
    ÆòÇü¿°¾×
  • bromine solution
    ºê·Ò¿ë¾×
  • buffer solution
    ¿ÏÃæ¾×
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • contact scrotal thermography
    À½³¶Á¢Ã˿µµÃøÁ¤¼ú
  • heel contact
    µÚÃàµó±â
  • immediate contact
    Áï½ÃÁ¢ÃË
  • indirect contact
    °£Á¢Á¢ÃË
  • intercellular contact
    ¼¼Æ÷»çÀÌÁ¢ÃËÃþ
  • primary contact
    ÀÏÂ÷Á¢ÃË
  • proximal contact
    ÀÎÁ¢
  • secondary contact
    ÀÌÂ÷Á¢ÃË
  • three point balancing contact
    »ïÁ¡Á¢Ã˱³ÇÕ
  • photoallergic contact dermatitis
    ±¤¾Ë·¹¸£±âÁ¢ÃËÇǺο°
  • intercellular contact layer
    ¼¼Æ÷°£Á¢ÃËÃþ
  • alkaline solution
    ¾ËÄ®¸®¿ë¾×
  • anisotonic solution
    ºñµîÀå¾×
  • aqueous solution
    ¼ö¾ç¾×, ¹°¿ë¾×
  • aseptic solution
    ¹«±Õ¾×
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Lugols solution
    ·ç°ñ¾× (±×¶÷¿°»ö¿ë ¸Å¿°Á¦)
  • Ringer s solution
    ¸µ°Å¾×.
  • Ringers solution
    ¸µ°Å¾×
  • Tyrodes solution
    Ƽ·Îµå¾×
  • anisotonic solution
    ºñµîÀå¾×
  • aqueous solution
    ¼ö¾ç¾×(â©åÆäû)
  • aseptic solution
    ¹«±Õ¾×(¡­äû).
  • aseptic solution
    ¹«±Õ¾×(¡­¾×).
  • glycerin and potash solution
    ±Û¸®¼¼¸° Ä®·ý¾×.
  • half normal solution
    0.5 ±ÔÁ¤¾×(¡­Ð®ïÒäû).
  • heavy solution
    Áß¾×(ñìäû).
  • hydrogen peroxide solution
    °ú»êÈ­¼ö¼Ò¼ö(Φ߫ûùâ©áÈ).
  • hypochromatosis =nuclear solution
    (ÇÙ)¿°Áú°¨¾à(ú·æøòõÊõå°) ÇÙºØA , ÇǺλö¼ÒÄ§Âø°¨¼ÒÁõ(ù«Ý±ßäáÈ ó·Êõá´ñø).
  • hypotonic salt solution
    ÀúÀå½Ä¿°¼ö(î¸íåãÝç¤â©).
  • hypotonic solution
    ÀúÀ强¿ë¾×(î¸íåàõéÁäû).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • contact allergy
    Á¢Ã˼º ¾Ë·¹¸£±â
  • contact angle
    Á¢Ã˰¢(ïÈõºÊÇ).
  • contact area
    ´ê´ÂºÎºÐ
  • contact blepharitis
    Á¢ÃË´«²¨Ç®¿°Áõ, Á¢Ã˾Ȱ˿°
  • contact carrier
    Á¢Ã˺¸±ÕÀÚ(ÊÙËÓË»Ëö).
  • contact cheilitis
    Á¢ÃË(ïÈõº) ÀÔ¼ú¿°
  • contact comfort
    Á¢ÃËÀ§¾È(ïÈõºêÐäÌ)
  • contact compound scan
    Á¢ÃË º¹ÇÕ ½ºÄµ
  • contact compound scan
    Á¢ÃË º¹ÇÕ (ïÈõº ÜÜùê) ½ºÄµ
  • contact compound scanner
    Á¢ÃË º¹ÇÕ (ïÈõº ÜÜùê) ½ºÄ³³Ê
  • contact dermatitis
    Á¢ÃËÇǺο°(ù«Ý±æú)
  • contact dermatitis
    Á¢Ã˼º ÇǺο°
  • contact dermatoconjunctivitis
    Á¢ÃËÇǺΰḷ¿°
  • contact eczema
    Á¢Ã˽ÀÁø
  • contact hypersensitivity
    Á¢Ã˼º °ú¹Î¹ÝÀÀ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • osmolal solution
    ¿À½º¸ô¶ö ¿ë¾×(éÁäû)
  • osmolar solution
    ¿À½º¸ô¶ó¸£ ¿ë¾×(éÁäû)
  • percent solution
    ÆÛ¼¾Æ® ¿ë¾×(éÁäû)
  • saturated solution
    Æ÷È­ ¿ë¾×(øéûùéÁäû)
  • solution
    ¿ë¾×(éÁäû)
  • solution hybridization
    ¿ë¾×(éÁäû) Æ¢±âÇü¼º(û¡à÷)
  • standard solution
    Ç¥ÁØ¿ë¾×(øöñÞéÁäû)
  • supersaturated solution
    °úÆ÷È­ ¿ë¾× (ΦøéûúéÁäû)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
GEMSS glaucoma-lens ecopia-microspherophakia-stiffness-shortness syndrome
ICL idiopathic CD4 T-cell lymphocytopenia; iris-clip lens; isocitrate lyase
IOL induction of labor; intraocular lens
PCL pacing cycle length; persistent corpus luteum; plasma cell leukemia; posterior chamber lens; posteri...
Phaco lens phacoemulsification [ophthalmic cataract surgery]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CMR contact micro radiography
CPS contact photosensitivity
BLEC bovine lens epithelial cell
HLE Human lens epithelial
IOL Intra Ocular Lens
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • wide angle lens
    ±¤°¢ ·»Áî
  • acetic acid solution
    ¾Æ¼¼Æ® »ê ¿ë¾×
  • alkaline solution
    ¾ËÄ®¸®¼º ¿ë¾×
  • aqueous solution
    ¼ö¾ç ¾×, ¼ö¿ë¾×
    ¿ë¸Å·Î¼­ ¹°ÀÌ »ç¿ëµÇ´Â ¿ë¾×.
  • artificial calcifying solution
    Àΰø ¼®È¸È­ ¾×, Àΰø ¼®È¸È­ ¿ë¾×
  • boric acid solution
    ºØ»ê ¼ö
  • cardioplegic solution
    ½É Á¤Áö ¿ë¾×
  • Carnoy's solution
    Carnoy ¿ë¾×
  • cetrimide-citrate-saline solution
    ¼¼Æ®¸®¹ÌÀ̵å-±¸¿¬»ê-½Ä¿° ¿ë¾×
  • cleansing solution
    ûÁ¤ ¾×, ÀÇÄ¡ û°á ¿ë¾×
  • conjugate solution
    ¦ ¿ë¾×
  • developing solution
    Çö»ó ¾×
  • diluted ammonia solution
    Èñ¼® ¾Ï¸ð´Ï¾Æ¼ö
    ¹«»ö Åõ¸íÇÑ ¾ËÄ®¸®¼º ¿ë¾×. 100ml Áß¿¡ 9¡­10gÀÇ ¾Ï¸ð´Ï¾Æ¸¦ ÇÔÀ¯ÇÑ´Ù. Á¦¾à¿¡ ÇʼöÀûÀ¸·Î »ç¿ëµÈ´Ù.
  • disclosing solution
    Ä¡ÅÂ Âø»ö¾×
    Ä¡¾Æ Ç¥¸é¿¡ ¹ß¶ó¼­ ¼úÀÚ ¶Ç´Â ȯÀÚ°¡ ±× Ç¥¸é¿¡ ºÙ¾î ÀÖ´Â Ä¡¼®À̳ª ±âŸ Ä§Âø¹°À» º¼ ¼ö ÀÖµµ·Ï Á¶¼ºµÈ ¿ë¾×.
  • equimolecular solution
    µîºÐÀÚ ¿ë¾×
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
contact point That part of the proximal surface of a tooth which touches the adjacent tooth mesially or distally.
Synonym: contact point, point of proximal contact.
(05 Mar 2000)
contact rate <epidemiology> The rate at which susceptibles meet infecteds. Usually measured as individuals per unit time.
(05 Dec 1998)
contact sensitivity Allergic response to contact with irritant, usually a hypersensitivity.
(18 Nov 1997)
contact sites A Developmentally regulated adhesion sites that appear on the ends of aggregation competent Dictyostelium discoideum at the stage when the starved cells begin to come together to form the grex. Originally detected by the use of Fab fragments of polyclonal antibodies, raised against aggregation competent cells and adsorbed against vegetative cells, to block adhesion in EDTA containing medium. (Cell cell adhesion mediated by contact sites A, unlike that mediated by contact sites B, is not divalent cation sensitive). The fact that a mutant deficient in csA behaves perfectly normally in culture is puzzling.
(18 Nov 1997)
contact sites B Developmentally regulated adhesion sites that appear on the ends of aggregation competent Dictyostelium discoideum at the stage when the starved cells begin to come together to form the grex. Originally detected by the use of Fab fragments of polyclonal antibodies, raised against aggregation competent cells and adsorbed against vegetative cells, to block adhesion in EDTA containing medium. (Cell cell adhesion mediated by contact sites A, unlike that mediated by contact sites B, is not divalent cation sensitive). The fact that a mutant deficient in csA behaves perfectly normally in culture is puzzling.
(18 Nov 1997)
contact splint A slotted plate, held by screws, used in the treatment of fracture of long bones.
(05 Mar 2000)
contact surface of tooth The surface of a tooth that faces an adjacent tooth in the dental arch; the contact surface that is closest to the anterior midline of the dental arch is the mesial surface of a tooth; that farthest is the distal surface.
Synonym: facies approximalis dentis, facies contactus dentis.
(05 Mar 2000)
contact tracing Identification of those persons (or animals) who have had such an association with an infected person, animal, or contaminated environment as to have had the opportunity to acquire the infection. Contact tracing is a generally accepted method for the control of sexually transmitted diseases.
(12 Dec 1998)
contact-type dermatitis Dermatitis resembling contact dermatitis or eczema, but caused by an ingested or injected allergen, usually a drug, and with a widespread or generalised distribution.
(05 Mar 2000)
point of proximal contact That part of the proximal surface of a tooth which touches the adjacent tooth mesially or distally.
Synonym: contact point, point of proximal contact.
(05 Mar 2000)
premature contact A condition of tooth contact's which diverts the mandible from a normal path of closure to centric jaw relation.
Synonym: cuspal interference, interceptive occlusal contact, premature contact.
(05 Mar 2000)
proximal contact Proximate contact, the area where the surfaces of two adjacent teeth in the same arch touch.
Contact with reality, correctly interpreting external phenomena in relation to the norms of one's social or cultural milieu.
Working contacts, working or occlusion; contact's of teeth made on the side of the occlusion toward which the mandible has been moved.
Synonym: working bite, working occlusion.
(05 Mar 2000)
screen-film contact The closeness and uniformity with which the X-ray film in a cassette lies against the screen. Image resolution is dependent on this closeness and uniformity of contact.
(05 Mar 2000)
nonreciprocal contact inhibition <cell biology> Collision behaviour between different cell types in which one cell shows contact inhibition of locomotion and the other does not. An example is the interaction between sarcoma cells and fibroblasts (the former not being inhibited).
(18 Nov 1997)
deflective occlusal contact A condition of tooth contact's which diverts the mandible from a normal path of closure to centric jaw relation.
Synonym: cuspal interference, interceptive occlusal contact, premature contact.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • contact agent
    Ã˸Å;Á¢ÃËÁ¦(catalyzer)
  • contact approach
    À¯½Ã°è ÁøÀÔ
  • contact breaker
    (Àü·ùÀÇ) Â÷´Ü±â
  • contact catalysis
    Á¢ÃË(Ã˸Å)ÀÛ¿ë
  • contact dermatitis
    Á¢ÃË ÇǺο°
  • contact electricity
    Á¢ÃËÀü±â
  • contact flying(flight)
    Á¢ÃË ºñÇà;À¯½Ã°èºñÇà
  • contact high
    °¨¿°(°£Á¢) µµÃë(¸¶¾àµµÃëÀÚ¿Í Á¢Çϰųª ¿¬±â³¿»õ·Î ÃëÇϱâ)
  • contact ingibition
    Á¢ÃËÀúÁö(¹è¾ç¼¼Æ÷°¡ ¼­·Î Á¢ÃËÇÏ¿© ±â´ÉÀÌ Á¤ÁöµÇ±â)
  • contact maker
    (Àü·ùÀÇ)Á¢Ã˱â
  • contact man
    (°Å·¡µîÀÇ)Áß°³ÀÚ;Á¤º¸Á¦°øÀÚ;(°ü°ø¼­µî¿¡ ´ëÇÑ)¼·¿ÜÀÚ;(½ºÆÄÀ̵îÀÇ)¿¬¶ô¿ø
  • contact metamorphism
    Á¢Ã˺¯¼ºÀÛ¿ë
  • contact mine
    Ã˹߼ö·Ú(±â·Ú,Áö·Ú)
  • contact paper
    ¹ÐÂø(ÀÎÈ­)Áö
  • contact potential
    Á¢ÃË ÀüÀ§Â÷
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á